secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001193125-23-146147
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARS Pharmaceuticals releases revised corporate presentation highlighting its needle-free epinephrine device
--------------------------------------------------------------------------------

- ARS Pharmaceuticals released a revised corporate presentation on May 16, 2023.
- Presentation highlights the company's needle-free epinephrine product for allergic reactions.
- No earnings, clinical results, or regulatory milestones were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312523146147/0001193125-23-146147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312523146147/d434574d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-146147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer